US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Horizon Kinetics Blockchain Development ETF

31.99

-0.0573-0.18%

Post-market: 32.080.0863+0.27%16:10 EDT

Volume:634

Turnover:20.34K

Market Cap:23.20M

PE:- -

High:32.08

Open:32.08

Low:31.99

Close:32.05

52wk High:36.27

52wk Low:29.01

Shares:725.00K

Float Shares:725.00K

Volume Ratio:0.36

T/O Rate:0.09%

Dividend:0.76

Dividend Rate:2.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Silexion Therapeutics Says Holders Exercise Warrants for 3,216,928 Shares at $0.2603 Each

Apyx Medical Reports Renuvion Study Shows Increased Elastin, Reduced Inflammation at 180 Days

Imunon Converts USD 1.2 Million Debt into Newly Issued Preferred Shares

Brunswick Names Will Sangster President of Navico Group Effective Jan. 1, 2027

Veracyte Decipher Prostate Test Predicts Benefit of Adding Hormone Therapy to Radiation in Phase III Trial Analysis

Savaria Chairman Marcel Bourassa Sells Shares for $85.05 Million

Tokyo Lifestyle Converts JPY 510 Million Shareholder Loan into Equity

SaverOne Wins New U.S. Patent for Automated Sensor Fusion Calibration Maintenance

Outdoor Holding to Host Fiscal Q2 Earnings Call

NewAmsterdam Pharma Doses First Patient in Phase 2b Spinoza Trial of Obicetrapib in Preclinical Alzheimer’s Disease

Max Power Mining Says Lawson 5 Well Nears Prairie Evaporite Salt Horizon in Natural Hydrogen Step-Out Program

Ice Launches New Jkm LNG (Platts) Options, LNG Balmo Freight Futures and U.k. Electricity Options in an Expansion of Global Natural Gas and Power Markets

THOMSON REUTERS

Byrna Shifts iHeartMedia Ad Spend to Bobby Bones Show to Broaden Mainstream Reach

Axil Brands Updates Financial Calendar with Upcoming Quarterly Results Release and Investor Call

Maris-Tech Completes Development of Diamond Ultra V2 Video and AI Platform

Dianthus Therapeutics to Present Phase 3 Captivate Interim Analysis of Claseprubart in CIDP at 2026 AANEM Meeting

AgEagle Anti-Jamming Technology Performs Strongly in Army DDIL Testing, Nears Production Readiness

Phathom Begins Phase 3 Trial of Voquezna As-Needed Dosing in Non-Erosive GERD Patients

Beta Bionics to Report Q3 2026 Results, Host Conference Call and Webcast

TMC Appoints Former ExxonMobil Upstream President Liam Mallon to Board

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BCDF/news?page=35"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BCDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","market":"US","secType":"STK","nameCN":"Horizon Kinetics Blockchain Development ETF","latestPrice":31.9937,"timestamp":1790971200000,"preClose":32.051,"halted":0,"volume":634,"hourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":31.9937,"latestTime":"16:10 EDT","volume":6,"amount":191.9622,"timestamp":1790971804464,"change":0.0863,"changeRate":0.002697,"amplitude":0},"delay":0,"changeRate":-0.001787775732426491,"floatShares":725000,"shares":725000,"eps":0,"marketStatus":"Market Closed","change":-0.0573,"latestTime":"10-02 16:00:00 EDT","open":32.08,"high":32.08,"low":31.9937,"amount":20343,"amplitude":0.002693,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":32.051,"sharesOutstanding":675000,"nav":32.17,"aum":23323250,"dividendRate":0.023836,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":31.9937,"latestTime":"16:10 EDT","volume":6,"amount":191.9622,"timestamp":1790971804464,"change":0.0863,"changeRate":0.002697,"amplitude":0},"volumeRatio":0.3561797412637326},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","floatShares":725000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3561797412637326,"shares":725000,"dividePrice":0.7626,"high":32.08,"amplitude":0.002693,"preClose":32.051,"low":31.9937,"week52Low":29.01,"pbRate":"--","week52High":36.27,"institutionHeld":0,"latestPrice":31.9937,"eps":0,"divideRate":0.023836,"volume":634,"delay":0,"ttmEps":0,"open":32.08,"prevYearClose":30.2172,"prevWeekClose":32.4777,"prevMonthClose":32.0003,"prevQuarterClose":32.0003,"fiveDayClose":32.4777,"twentyDayClose":34.0114,"sixtyDayClose":31.0085},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDF\",params:#limit:5,,,undefined,":[{"date":"2024-12-24","symbol":"BCDF","amount":0.45302,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"Horizon Kinetics Blockchain Development ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"BCDF","amount":0.169967,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"},{"market":"US","date":"2022-12-28","symbol":"BCDF","amount":0.05244,"defaultRemindTime":1672237800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2022-09-28","symbol":"BCDF","amount":0.0219,"defaultRemindTime":1664371800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-09-30","payableDate":"2022-09-29","currency":"USD","type":"dividend","dateTimestamp":1664337600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDF\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-28","recordDate":"2022-09-29","paymentDate":"2022-09-30","value":0.0219,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.05244,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.169967,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.45302,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCDF\",pageSize:20,pageCount:35,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671211114","title":"Silexion Therapeutics Says Holders Exercise Warrants for 3,216,928 Shares at $0.2603 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211114","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211114?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:07","pubTimestamp":1790683646,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics says holders exercise warrants for 3,216,928 shares at $0.2603 eachSilexion entered definitive agreements for immediate exercise of Series E warrants for 3,216,928 ordinary share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLTxVk7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","SLXN","BK4112","LU2210149790.SGD","BK4139","IE00BQXX3C00.GBP","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","BCDF","NDAQ","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671191211","title":"Apyx Medical Reports Renuvion Study Shows Increased Elastin, Reduced Inflammation at 180 Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2671191211","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671191211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:07","pubTimestamp":1790683632,"startTime":"0","endTime":"0","summary":"Apyx Medical reports Renuvion study shows increased elastin, reduced inflammation at 180 daysApyx Medical disclosed results from a prospective clinical study of its Renuvion device, now published in a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL9Z8nrx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU0314104364.USD","BK4585","LU2095319765.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","SG9999014039.USD","SG9999014005.SGD","BK4112","BK4588","IE00BN0W2W23.USD","BK4082","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BCDF","APYX","SG9999014013.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211199","title":"Imunon Converts USD 1.2 Million Debt into Newly Issued Preferred Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211199","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211199?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:07","pubTimestamp":1790683620,"startTime":"0","endTime":"0","summary":"Imunon converts USD 1.2 million debt into newly issued preferred sharesImunon exchanged USD 1.2 million of A-1 Note principal, accrued interest for 120 shares of newly designated Series B Preferred St","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL1RcFFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","BCDF","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4588","BK4112","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","IMNN","BK4585","LU2095319765.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4139","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671321116","title":"Brunswick Names Will Sangster President of Navico Group Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2671321116","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671321116?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:06","pubTimestamp":1790683565,"startTime":"0","endTime":"0","summary":"Brunswick names Will Sangster president of Navico Group effective Jan. 1, 2027Brunswick named Will Sangster executive vice president, president of Navico Group, effective Jan. 1, 2027.Sangster current","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL66WXqR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014021.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014013.SGD","BK4585","BK4190","BCDF","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","BK4588","BC","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211928","title":"Veracyte Decipher Prostate Test Predicts Benefit of Adding Hormone Therapy to Radiation in Phase III Trial Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211928","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211928?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:05","pubTimestamp":1790683539,"startTime":"0","endTime":"0","summary":"Veracyte Decipher Prostate test predicts benefit of adding hormone therapy to radiation in Phase III trial analysisVeracyte flagged new Decipher Prostate test data from a retrospective analysis of the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL5NNL37:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","IE00B64PRP62.GBP","BK4588","BK4139","BK4112","IE00BQXX3C00.GBP","BCDF","SG9999014039.USD","VCYT","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00BGHQF748.EUR","BK4585","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","SG9999014013.SGD","FBT","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671135211","title":"Savaria Chairman Marcel Bourassa Sells Shares for $85.05 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2671135211","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671135211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:05","pubTimestamp":1790683523,"startTime":"0","endTime":"0","summary":"Savaria chairman Marcel Bourassa sells shares for $85.05 millionSavaria Executive Chairman Marcel Bourassa sold 3,000,000 common shares at CAD 28.35 each via the TSX.Transaction value totaled CAD 85.0","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8p0tyb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Savaria Chairman Marcel Bourassa Sells Shares for $85.05 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BQXX3F31.USD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4588","SG9999014005.SGD","BCDF","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671821191","title":"Tokyo Lifestyle Converts JPY 510 Million Shareholder Loan into Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671821191","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671821191?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:05","pubTimestamp":1790683512,"startTime":"0","endTime":"0","summary":"Tokyo Lifestyle converts JPY 510 million shareholder loan into equityTokyo Lifestyle will convert JPY 510 million of shareholder-related loan principal into 12,106,893 newly issued ordinary shares on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8PlRKg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00B64PRP62.GBP","BK4112","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","NDAQ","BK4585","LU2095319765.USD","BK4588","BK4200","IE00BN0W2W23.USD","LU0314104364.USD","TKLF","IE00BN0W2V16.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671921118","title":"SaverOne Wins New U.S. Patent for Automated Sensor Fusion Calibration Maintenance","url":"https://stock-news.laohu8.com/highlight/detail?id=2671921118","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671921118?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:05","pubTimestamp":1790683510,"startTime":"0","endTime":"0","summary":"SaverOne wins new U.S. patent for automated sensor fusion calibration maintenanceSaverOne won a new U.S. patent covering automated sensor-fusion calibration and maintenance for its in-vehicle Phone Lo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLc3FRjG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014013.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4588","SG9999014039.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211996","title":"Outdoor Holding to Host Fiscal Q2 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211996","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211996?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:05","pubTimestamp":1790683501,"startTime":"0","endTime":"0","summary":"Outdoor Holding to host fiscal Q2 earnings callOutdoor Holding Company schedules release of fiscal 2027 second-quarter results premarket on Nov. 16, 2026.Management to host an earnings conference call","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL6nzrXK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2210149790.SGD","IE00BQXX3C00.GBP","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","BCDF","NDAQ","IE00BN0W2T93.GBP","SG9999014005.SGD","BK4200","POWW","IE00BQXX3D17.EUR","GUNZ","SG9999014039.USD","BK4190","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671121198","title":"NewAmsterdam Pharma Doses First Patient in Phase 2b Spinoza Trial of Obicetrapib in Preclinical Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2671121198","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671121198?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:04","pubTimestamp":1790683483,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma doses first patient in Phase 2b SPINOZA trial of obicetrapib in preclinical Alzheimer’s diseaseNewAmsterdam Pharma dosed the first participant in SPINOZA, a Phase 2b trial of obice","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL9S3dTC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","IE00BQXX3C00.GBP","NAMS","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671119852","title":"Max Power Mining Says Lawson 5 Well Nears Prairie Evaporite Salt Horizon in Natural Hydrogen Step-Out Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671119852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671119852?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:04","pubTimestamp":1790683468,"startTime":"0","endTime":"0","summary":"Max Power Mining says Lawson 5 well nears Prairie Evaporite salt horizon in natural hydrogen step-out programMax Power Mining reported Lawson 5 drilling is on track, with intermediate casing set at ab","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLXysHv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2210149790.SGD","IE00BQXX3C00.GBP","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","BCDF","NDAQ","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671421164","title":"Ice Launches New Jkm LNG (Platts) Options, LNG Balmo Freight Futures and U.k. Electricity Options in an Expansion of Global Natural Gas and Power Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2671421164","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671421164?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:03","pubTimestamp":1790683387,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0154236417.USD","BK4112","LU0154245756.USD","LU0124676726.USD","LU2023250504.SGD","LU0949170772.SGD","LU0477156953.USD","LU2023250843.SGD","ICE","LU0648001328.SGD","LU0971096721.USD","LU1917777945.USD","LU0661504455.SGD","LU0256863811.USD","LU0011850046.USD","LU2237957811.SGD","IE00BQXX3C00.GBP","LU0980610538.SGD","LU1506573853.SGD","LU2237957902.USD","LU0738911758.USD","LU0130517989.USD","LU0417517546.SGD","LU1974910355.USD","LU1201861249.SGD","SG9999004303.SGD","LU0072461881.USD","LU1153585028.USD","LU0154245673.USD","LU0256863902.USD","LU2106854487.HKD","BK4588","LU1363072403.SGD","LU0130102774.USD","IE00BQXX3F31.USD","GB00BDT5M118.USD","LU0689626769.HKD","LU0162691827.USD","LU0314106906.USD","BCDF","BK4585","SGXZ23171101.USD","IE00BQXX3D17.EUR","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671614211","title":"Byrna Shifts iHeartMedia Ad Spend to Bobby Bones Show to Broaden Mainstream Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2671614211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671614211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:02","pubTimestamp":1790683362,"startTime":"0","endTime":"0","summary":"Byrna shifts iHeartMedia ad spend to Bobby Bones Show to broaden mainstream reachByrna Technologies will shift marketing spend within its iHeartMedia portfolio toward programming with broader mainstre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL9f6hWR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","IE00BQXX3C00.GBP","IHRT","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BQXX3F31.USD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","BYRN","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","BK4187","IE00BGHQF748.EUR","BK4125","NDAQ","BK4588","SG9999014005.SGD","BCDF","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211690","title":"Axil Brands Updates Financial Calendar with Upcoming Quarterly Results Release and Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211690","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211690?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:02","pubTimestamp":1790683356,"startTime":"0","endTime":"0","summary":"Axil Brands updates financial calendar with upcoming quarterly results release and investor callAxil Brands schedules fiscal Q1 results for the period ended Aug. 31, 2026 on Oct. 6, 2026, post-market.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLbsm2tv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4112","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","LU2095319765.USD","NDAQ","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BK4183","LU2210150020.SGD","BK4585","IE00BKPKM429.USD","IE00B3QW5Z07.USD","AXIL","SG9999014005.SGD","IE00BN0W2T93.GBP","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671421152","title":"Maris-Tech Completes Development of Diamond Ultra V2 Video and AI Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2671421152","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671421152?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:01","pubTimestamp":1790683299,"startTime":"0","endTime":"0","summary":"Maris-Tech completes development of Diamond Ultra V2 video and AI platformMaris-Tech completed development of its Diamond Ultra V2 next-generation high-performance video and AI platform for defense, S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL4sbyJ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BCDF","NDAQ","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4157","BK4585","IE00BQXX3F31.USD","SG9999014021.USD","LU2095319765.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BN0W2W23.USD","MTEK","LU0314104364.USD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671521211","title":"Dianthus Therapeutics to Present Phase 3 Captivate Interim Analysis of Claseprubart in CIDP at 2026 AANEM Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2671521211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671521211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:01","pubTimestamp":1790683277,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics to present Phase 3 CAPTIVATE interim analysis of claseprubart in CIDP at 2026 AANEM meetingDianthus Therapeutics flagged new clinical updates for its complement inhibitor clasepr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL62W9hR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","BK4585","IBRN","BK4139","LU2210150020.SGD","BK4112","BCDF","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","DNTH","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221158","title":"AgEagle Anti-Jamming Technology Performs Strongly in Army DDIL Testing, Nears Production Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671221158?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683258,"startTime":"0","endTime":"0","summary":"AgEagle anti-jamming technology performs strongly in Army DDIL testing, nears production readinessAgEagle Aerial Systems’ EagleNXT unit reported strong DDIL test results for newly developed anti-jammi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL6fyS3P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","UAVS","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3C00.GBP","LU0314104364.USD","SG9999014013.SGD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","BK4152","BK4603","BK4585","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671309211","title":"Phathom Begins Phase 3 Trial of Voquezna As-Needed Dosing in Non-Erosive GERD Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2671309211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671309211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683252,"startTime":"0","endTime":"0","summary":"Phathom begins Phase 3 trial of VOQUEZNA as-needed dosing in non-erosive GERD patientsPhathom Pharmaceuticals began screening patients for a registrational Phase 3 trial of VOQUEZNA as-needed dosing i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL3CxjmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","BCDF","IE00BGHQF748.EUR","NDAQ","PHAT","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","BK4588","LU0314104364.USD","BK4585","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","BK4007","IE00BQXX3C00.GBP","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671115892","title":"Beta Bionics to Report Q3 2026 Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2671115892","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671115892?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683236,"startTime":"0","endTime":"0","summary":"Beta Bionics to report Q3 2026 results, host conference call and webcastBeta Bionics schedules Q3 2026 results release for Oct. 27, 2026, following the US market close.Management to host an earnings c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL6Glv1Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2210150020.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","NDAQ","SG9999014021.USD","BK4588","IE00BQXX3F31.USD","BK4082","IE00BQXX3D17.EUR","BBNX","SG9999014013.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4112","SG9999014005.SGD","IE00BGHQF748.EUR","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","SG9999014039.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211302","title":"TMC Appoints Former ExxonMobil Upstream President Liam Mallon to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211302","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211302?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683232,"startTime":"0","endTime":"0","summary":"TMC appoints former ExxonMobil Upstream president Liam Mallon to boardTMC appointed Liam Mallon, former President of ExxonMobil Upstream Company, to its board of directors.Mallon brings more than 40 y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL1KfN5t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","BK4563","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","SG9999014021.USD","BK4168","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","TMC","SG9999014005.SGD","BK4588","LU2095319765.USD","IE00BQXX3F31.USD","BCDF","BK4585","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":81,"pageCount":35,"totalSize":1603,"code":"91000000","status":"200"}]}}